Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
Sydney, New South Wales-based Nyrada Inc. operates in Pharmaceutical Manufacturing. Publicly held, at nyrada.com. It holds one address on record, all in Australia. It employs 13 people, on the record. It is listed alongside nine similar brands, mostly in Biotechnology Research.
Nyrada Inc (ASX:NYR) is a US registered, Australia domiciled clinical-stage biotechnology company developing Transient Receptor Potential Canonical (TRPC) ion channel inhibitors to treat a range of medical conditions.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
13 counted staff profiles at January 2026, above the self-reported 2–10 band.
One address on record, Australia only. Primary: 180 George St, Level 22/23, Salesforce Tower, Sydney, New South Wales 2000.
None linked to this brand.
4 profiles list Nyrada Inc. (ASX:NYR) as a peer — 67th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Atticus Medical lists it back.